HOUSTON, Oct. 12, 2017 -- Sharps Compliance Corp. (Nasdaq:SMED) announced today that it will release its first quarter results for the period ended September 30, 2017, before the opening of the financial markets on Wednesday, October 25, 2017. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company’s financial results, key market initiatives and business strategy.
The Sharps conference call can be accessed by domestic callers by dialing (877) 407-0782. International callers may access the call by dialing (201) 689-8567. The webcast can be monitored at www.sharpsinc.com.
A telephonic replay will be available through November 25, 2017. To listen to the replay, domestic callers should dial (877) 481-4010 and international callers should dial (919) 882-2331 and enter replay ID number 20971. Transcript will also be posted to the Sharps website, once available.
About Sharps Compliance Corp.
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living / long-term care, surgery centers, retail pharmacies and clinics, and the professional market which is comprised of physicians, dentists and veterinary practices. The Company's flagship product, the Sharps Recovery System, is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and other used healthcare materials. The Company also offers its route-based pick-up service in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States.
More information on the Company and its products can be found on its website at: www.sharpsinc.com
Safe Harbor Statement
The information made available in this news release contains certain forward-looking statements which reflect Sharps Compliance Corp.'s current view of future events and financial performance. Wherever used, the words "estimate," "expect," "plan," "anticipate," "believe," "may" and similar expressions identify forward-looking statements. Any such forward-looking statements are subject to risks and uncertainties and the company's future results of operations could differ materially from historical results or current expectations. Some of these risks include, without limitation, the company's ability to educate its customers, development of public awareness programs to educate the identified consumer, customer preferences, the Company's ability to scale the business and manage its growth, the degree of success the Company has at gaining more large customer contracts, managing regulatory compliance and/or other factors that may be described in the company's annual report on Form 10-K, quarterly reports on Form 10-Q and/or other filings with the Securities and Exchange Commission. Future economic and industry trends that could potentially impact revenue and profitability are difficult to predict. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results, express or implied therein, will not be realized.
Company Contact:
Diana Diaz
Sharps Compliance Corp.
Email: [email protected]
Office: (713) 660-3547
Investor Contact:
John Nesbett/Jennifer Belodeau
Institutional Marketing Services
Email: [email protected]
Office: (203) 972-9200


Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 



